AR041472A1 - Complejos de carbohidrato de hierro acuosos su produccion y medicamentos que los contienen - Google Patents

Complejos de carbohidrato de hierro acuosos su produccion y medicamentos que los contienen

Info

Publication number
AR041472A1
AR041472A1 ARP030103595A ARP030103595A AR041472A1 AR 041472 A1 AR041472 A1 AR 041472A1 AR P030103595 A ARP030103595 A AR P030103595A AR P030103595 A ARP030103595 A AR P030103595A AR 041472 A1 AR041472 A1 AR 041472A1
Authority
AR
Argentina
Prior art keywords
production
iron
iron carbohydrate
medicines containing
carbohydrate compounds
Prior art date
Application number
ARP030103595A
Other languages
English (en)
Inventor
Peter Geisser
Erik Philipp
Walter Richle
Original Assignee
Vifor Int Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=32102937&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AR041472(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Vifor Int Ag filed Critical Vifor Int Ag
Publication of AR041472A1 publication Critical patent/AR041472A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B31/00—Preparation of derivatives of starch
    • C08B31/18—Oxidised starch
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B30/00—Preparation of starch, degraded or non-chemically modified starch, amylose, or amylopectin
    • C08B30/12—Degraded, destructured or non-chemically modified starch, e.g. mechanically, enzymatically or by irradiation; Bleaching of starch
    • C08B30/18—Dextrin, e.g. yellow canari, white dextrin, amylodextrin or maltodextrin; Methods of depolymerisation, e.g. by irradiation or mechanically
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/28—Compounds containing heavy metals
    • A61K31/295—Iron group metal compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A61K31/718—Starch or degraded starch, e.g. amylose, amylopectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/26—Iron; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/61—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule the organic macromolecular compound being a polysaccharide or a derivative thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H23/00—Compounds containing boron, silicon, or a metal, e.g. chelates, vitamin B12
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B31/00—Preparation of derivatives of starch
    • C08B31/18—Oxidised starch
    • C08B31/185—Derivatives of oxidised starch, e.g. crosslinked oxidised starch
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/0006—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
    • C08B37/0009—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid alpha-D-Glucans, e.g. polydextrose, alternan, glycogen; (alpha-1,4)(alpha-1,6)-D-Glucans; (alpha-1,3)(alpha-1,4)-D-Glucans, e.g. isolichenan or nigeran; (alpha-1,4)-D-Glucans; (alpha-1,3)-D-Glucans, e.g. pseudonigeran; Derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • Materials Engineering (AREA)
  • Polymers & Plastics (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Medicinal Preparation (AREA)

Abstract

Complejo de carbohidrato de hierro hidrosoluble obtenible a partir de una disolución acuosa de una sal de hierro (III) y una disolución acuosa del producto de oxidación de una o más maltodextrinas con un equivalente de dextrosa e 5 a 22 usando una disolución de hipoclorito sódico a pH de 8,5 a 12, procedimiento para su producción Y medicamento para el tratamiento de las enfermedades ferropénicas.
ARP030103595A 2002-10-23 2003-10-02 Complejos de carbohidrato de hierro acuosos su produccion y medicamentos que los contienen AR041472A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE10249552A DE10249552A1 (de) 2002-10-23 2002-10-23 Wasserlösliche Eisen-Kohlenhydrat-Komplexe, deren Herstellung und diese enthaltende Arzneimittel

Publications (1)

Publication Number Publication Date
AR041472A1 true AR041472A1 (es) 2005-05-18

Family

ID=32102937

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP030103595A AR041472A1 (es) 2002-10-23 2003-10-02 Complejos de carbohidrato de hierro acuosos su produccion y medicamentos que los contienen

Country Status (30)

Country Link
US (11) US7612109B2 (es)
EP (2) EP1554315B1 (es)
JP (2) JP4777653B2 (es)
KR (1) KR100992178B1 (es)
CN (1) CN100480275C (es)
AR (1) AR041472A1 (es)
AT (1) ATE507246T1 (es)
AU (1) AU2003278111C1 (es)
BR (2) BRPI0315452B8 (es)
CA (1) CA2493806C (es)
CY (2) CY1112680T1 (es)
DE (2) DE10249552A1 (es)
DK (2) DK1554315T3 (es)
ES (2) ES2385788T3 (es)
HK (2) HK1081976A1 (es)
IL (1) IL166747A (es)
JO (3) JO3286B1 (es)
MX (1) MXPA05004300A (es)
MY (1) MY134394A (es)
NO (2) NO333008B1 (es)
NZ (1) NZ539243A (es)
PE (1) PE20040571A1 (es)
PT (2) PT1554315E (es)
RU (1) RU2303039C2 (es)
SA (1) SA03240447B1 (es)
SI (2) SI2287204T1 (es)
TW (1) TWI265028B (es)
UY (1) UY28033A1 (es)
WO (1) WO2004037865A1 (es)
ZA (1) ZA200504174B (es)

Families Citing this family (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6757848B2 (en) 2001-06-19 2004-06-29 Hewlett-Packard Development Company, L.P. Recovery of user data from partially incorrect data set in tape data storage system
DE10249552A1 (de) 2002-10-23 2004-05-13 Vifor (International) Ag Wasserlösliche Eisen-Kohlenhydrat-Komplexe, deren Herstellung und diese enthaltende Arzneimittel
DE102004031181A1 (de) * 2004-06-28 2006-01-19 Vifor (International) Ag Phosphatadsorbens
ES2333814T3 (es) * 2005-02-09 2010-03-01 Vifor (International) Ag Uso de compuestos de complejo de hierro (iii).
ITMO20050056A1 (it) 2005-03-15 2006-09-16 Biofer Spa Processo per la preparazione di complessi del ferro trivalente con zuccheri mono-, di- e polisaccaridi.
EP1757299A1 (de) * 2005-08-25 2007-02-28 Vifor (International) Ag Eisen(III)-Komplexverbindungen zur Behandlung von Eisenmangel-Zuständen bei Patienten mit chronisch-entzündlicher Darmerkrankung
EP1790356A1 (de) * 2005-11-24 2007-05-30 Vifor (International) Ag Präparat, umfassend Eisen(III)-Komplexverbindungen und redoxaktive Substanz(en)
WO2007081744A2 (en) 2006-01-06 2007-07-19 Luitpold Pharmaceuticals, Inc. Methods and compositions for administration of iron
AU2013206429B2 (en) * 2006-01-06 2016-04-28 Vifor (International) Ag Methods and compositions for administration of iron
AU2016205002C1 (en) * 2006-01-06 2020-09-24 Vifor (International) Ag Methods and compositions for administration of iron
EP1941869A1 (en) * 2007-01-04 2008-07-09 Vifor (International) Ag Multicompartment bag for storage of iron preparations
EP1947120A1 (de) * 2007-01-19 2008-07-23 Vifor (International) Ag Eisen-Kohlenhydrat-Komplex-Verbindungen
MX2009008281A (es) * 2007-02-06 2009-08-25 Medical Res Council Materiales de ion metalico de poli-oxo-hidroxi modificados con ligando, sus usos y procesos para su preparacion.
EP1997833A1 (de) * 2007-05-29 2008-12-03 Vifor (International) Ag Wasserlösliche Eisen-Kohlenhydratderivat-Komplexe, deren Herstellung und diese enthaltende Arzneimittel
PT2411053T (pt) 2009-03-25 2017-02-15 Pharmacosmos Holding As Composto oligossacarídico de ferro estável
WO2011055374A2 (en) * 2009-11-04 2011-05-12 Symed Labs Limited Process for the preparation of iron (iii) carboxymaltose complex
WO2011117225A1 (de) 2010-03-23 2011-09-29 Vifor (International) Ag Fe(iii)-komplexverbindungen zur behandlung und prophylaxe von eisenmangelerscheinungen und eisenmangelanämien
WO2012104204A1 (en) 2011-01-31 2012-08-09 Vifor (International) Ag Iron-carbohydrate complex compounds for the intravenous therapy of malaria
US9370202B2 (en) 2013-03-15 2016-06-21 LG Bionano, LLC Encapsulated metal ion nanoclusters
US9384629B2 (en) 2014-03-31 2016-07-05 Fresh Idea Global Limited Automated money laundering detection, notification, and reporting techniques implemented at casino gaming networks
WO2015198304A1 (en) 2014-06-22 2015-12-30 Dexcel Pharma Technologies Ltd. Pharmaceutical compositions comprising ferric citrate and methods for the production thereof
EP2997968A1 (en) 2014-09-22 2016-03-23 Ioulia Tseti Iron (III) hydroxide complexes with activated glucose syrups and process for preparing same
CN104402984B (zh) * 2014-11-11 2018-09-07 武汉科福新药有限责任公司 一种高载铁量的蛋白琥珀酸铁的制备方法
US20180105609A1 (en) * 2015-03-23 2018-04-19 Suven Life Sciences Limited Preparation of water soluble trivalent iron carbohydrate complexes
WO2016181195A1 (en) 2015-05-08 2016-11-17 Suven Life Sciences Limited Improved process for water soluble iron carbohydrate complexes
WO2016196274A1 (en) * 2015-05-29 2016-12-08 Luitpold Pharmaceuticals, Inc. Compositions and methods for treatment of fibromyalgia
CN105125577B (zh) * 2015-07-29 2018-05-18 南京生命能科技开发有限公司 一种稳定的糖-铁复合物及其制备方法
CN105125578B (zh) * 2015-07-29 2018-05-11 南京生命能科技开发有限公司 一种具有高溶解速度的糖-铁复合物及其制备方法
US10258647B2 (en) 2015-09-01 2019-04-16 Particle Dynamics International, Llc Iron-polysaccharide complexes and methods for the preparation thereof
GB201517893D0 (en) 2015-10-09 2015-11-25 Medical Res Council Methods for producing carboxylate ligand modified ferric iron hydroxide colloids
CN105520955B (zh) * 2015-12-21 2018-05-11 南京生命能科技开发有限公司 一种羧基麦芽糖铁药用组合物及其制备方法
CN108129582A (zh) * 2016-12-01 2018-06-08 江苏奥赛康药业股份有限公司 一种铁碳水化合物复合物的制备方法
EP3339329A1 (en) 2016-12-22 2018-06-27 LEK Pharmaceuticals d.d. Selective oxidation of maltodextrin and its use in the preparation of water-soluble iron (iii) carboxymaltose complexes
CN111050802A (zh) 2017-09-11 2020-04-21 法码科思莫斯控股有限公司 用于治疗用途的铁络合物化合物
US20210155651A1 (en) * 2018-04-05 2021-05-27 Msn Laboratories Private Limited, R&D Center Process for the preparation of iron (iii) carboxymaltose
CN108498539A (zh) * 2018-05-03 2018-09-07 东营天东制药有限公司 一种水溶性铁剂复合体原料药的制备方法
MX2021004640A (es) 2018-10-29 2021-05-28 Pharmacosmos Holding As Tratamiento de la deficiencia de hierro con carboximaltosa ferrica.
EP3897661A1 (en) 2018-12-21 2021-10-27 Vifor (International) Ag Ferric carboxymaltose in the treatment of heart failure and in the treatment of congestion in heart failure
CN110218267B (zh) * 2019-07-04 2020-08-07 汉邦环宇多糖生物科技（河源）有限公司 一种右旋糖酐铁的制备方法及用途
US11447513B2 (en) * 2020-02-12 2022-09-20 Rk Pharma Inc. Purification process of ferric carboxymaltose
GB202005054D0 (en) 2020-04-06 2020-05-20 Nemysis Ltd Carboxylate Ligand Modified Ferric Iron Hydroxide Compositions for Use in the Treatment or Prevention of Iron Deficiency Associated with Liver Diseases
TWI784646B (zh) 2021-07-29 2022-11-21 台耀化學股份有限公司 製備羧基麥芽糖鐵的方法
WO2023041957A1 (en) * 2021-09-16 2023-03-23 Virchow Biotech Private Limited Efficient process for the synthesis of iron (iii) carbohydrate complexes
WO2024069644A1 (en) * 2022-09-30 2024-04-04 West Bengal Chemical Industries Limited A pharmaceutically acceptable ferric carboxymaltose and preparation thereof

Family Cites Families (114)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE370194C (de) 1923-02-28 Therese Rocksch Geb Laschet Elektrolytisches Zinnbad zur Darstellung schwammfreier Zinnkristalle
CA623411A (en) 1961-07-04 Muller Arthur Process for the manufacture of iron-polyisomaltose complex for therapeutical purposes
US1129307A (en) * 1914-12-26 1915-02-23 Howard L Marsh Process of forming compounds of iron and carbohydrates.
GB199951A (en) 1922-07-07 1923-07-05 William Swann Improvements in or relating to clamps or fastening devices for the brake chains of perambulators, and the like
DE461370C (de) 1925-06-13 1928-06-21 Chem Fab Vormals Sandoz Verfahren zur Herstellung von Monocarbonsaeuren aus Aldosen
GB289280A (en) 1927-06-17 1928-04-26 Chem Fab Vormals Sandoz Process for the oxidation of aldoses
GB335965A (en) 1929-06-05 1930-10-06 Ig Farbenindustrie Ag Process for the manufacture of complex iron compounds
US2807610A (en) 1952-02-15 1957-09-24 Baker Chem Co J T Hydrogenated dextran
GB748024A (en) 1953-02-27 1956-04-18 Benger S Ltd Improved therapeutic preparations of iron
GB828404A (en) * 1958-05-07 1960-02-17 Chugai Pharmaceutical Co Ltd A process for preparing divalent or trivalent metallic salts of glucuronic acid
GB879441A (en) 1959-05-25 1961-10-11 Crookes Lab Ltd Improved injectable iron preparations
US3065138A (en) 1959-10-09 1962-11-20 Warren Teed Products Company Therapeutic preparations of elemental iron
GB928238A (en) 1960-01-14 1963-06-12 Diamond Lab Inc Methods of preparing therapeutic preparations of iron
US3100202A (en) 1960-06-17 1963-08-06 Muller Arthur Process for preparing an iron hydroxide polyisomaltose complex and the resulting product
US3086009A (en) * 1960-07-19 1963-04-16 Diamond Lab Inc Process for preparing a water soluble hydrolyzed starch-ferric iron complex
GB978485A (en) 1960-10-26 1964-12-23 Astra Apotekarnes Kem Fab Iron preparations for intramuscular injection
GB928236A (en) 1960-11-22 1963-06-12 Atomic Energy Authority Uk Improvements in or relating to organic liquid moderated and cooled nuclear reactors
US3151107A (en) 1960-12-22 1964-09-29 Central Pharmacal Company Water-soluble iron complexes of carboxymethyl dextran
US3076798A (en) * 1961-02-23 1963-02-05 Hausmann Lab Ltd Process for preparing a ferric hydroxide polymaltose complex
GB985206A (en) 1961-12-20 1965-03-03 Hausmann Ag Labor Improvements in or relating to therapeutic iron preparation
ES282099A1 (es) 1962-11-02 1963-01-01 Rocador Sa Procedimiento para la preparación de un complejo de óxido de hierro y ácidos dextránicos
BE652508A (es) * 1963-08-30
FR1451203A (fr) * 1964-01-31 1966-01-07 Rocador Sa Procédé pour la fabrication d'un complexe d'oxyde ferrique et de polysaccharide
DE1617463A1 (de) * 1965-11-20 1971-04-08 Bayer Ag Verfahren zur Herstellung von injizierbaren kolloidalen Eisenzubereitungen
US3639588A (en) 1966-10-22 1972-02-01 Fisons Pharmaceuticals Ltd Pharmaceutical compositions containing ferric hydroxide complexed with dextran or dextrin heptonic acids
GB1183940A (en) 1966-10-22 1970-03-11 Fisons Pharmaceuticals Ltd Ferric Hydroxide Complexes
SE322866B (es) * 1966-12-15 1970-04-20 Astra Ab
GB1199951A (en) 1967-05-13 1970-07-22 Fisons Pharmaceuticals Ltd Modified Dextran and Derivatives Thereof
GB1200902A (en) * 1967-05-13 1970-08-05 Fisons Pharmaceuticals Ltd Iron-dextran complexes
US3395229A (en) 1967-07-03 1968-07-30 Mattox And Moore Inc Process and product for combatting iron deficiency anemia in suckling pigs
AT279048B (de) * 1967-07-04 1970-02-25 Pharmazeutische Fabrik Montavit Gmbh Verfahren zur Herstellung neuer, löslicher und stabiler organischer Eisen(III)-Komplexverbindungen und Injektionslösungen davon
GB1258566A (es) 1968-07-12 1971-12-30
US3908004A (en) * 1970-05-20 1975-09-23 C L Basingstoke Limited Process for making injectable iron compositions for treating iron-deficiency anemia
US3821192A (en) 1971-08-18 1974-06-28 Central Pharmacal Co Process for preparing an iron-saccharide complex
SE359447B (es) 1971-10-06 1973-09-03 Astra Laekemedel Ab
US3928581A (en) 1972-09-13 1975-12-23 Astra Laekemedel Ab Certain polymer-iron complexes for treatment of iron deficiency
US3969395A (en) 1972-10-04 1976-07-13 Astra Lakemedel Aktiebolag Polymers of hydroxy carboxylic acid and a polyhydric alcohol
US3965133A (en) 1972-10-04 1976-06-22 Astra Lakemedel Aktiebolag Polymer
US4056672A (en) 1973-03-22 1977-11-01 Astra Lakemedel Aktiebolag Polymer prepared by cyanhydrin method
JPS6039681B2 (ja) 1976-01-01 1985-09-07 日本臓器製薬株式会社 デキストリン・クエン酸・第二鉄多核複合体及び該複合体を含有する非経口用鉄剤
US4180567A (en) * 1977-09-02 1979-12-25 Pharmachem Corporation Iron preparations and methods of making and administering the same
US4370476A (en) 1979-07-17 1983-01-25 Usher Thomas C Dextran polycarboxylic acids, ferric hydroxide complexes
DE3026868C2 (de) * 1980-07-16 1986-03-13 Laboratorien Hausmann AG, St. Gallen Verfahren zur Herstellung von Eisen(III)hydroxid-Dextran-Komplexen und sie enthaltende pharmazeutische sterile wäßrige Lösung
US4335116A (en) 1980-10-07 1982-06-15 University Patents, Inc. Mineral-containing therapeutic compositions
EP0051707A1 (en) 1980-11-12 1982-05-19 Thomas Clemens Usher Dextran polycarboxylic acids, ferric hydroxide complexes thereof, pharmaceutical compositions containing them and methods for their manufacture
DE3114699A1 (de) 1981-04-10 1982-10-28 Siemens AG, 1000 Berlin und 8000 München Vorrichtung zum messen der roentgenroehrenhochspannung
HU187167B (en) 1982-10-15 1985-11-28 Richter Gedeon Vegyeszet Process for producing pharmaceutical solution of new type polynuclear iron/iii/ mixed complex activity
CS245379B1 (cs) 1983-12-12 1986-09-18 Karel Capek Způsob výroby komplexů sacharózy s biogenními prvky
US4788281A (en) 1984-01-04 1988-11-29 Tosoni Anthony L Dextran hexonic acid derivative, ferric hydroxide complex and method manufacture thereof
US5746999A (en) 1984-11-23 1998-05-05 Schering Aktiengesellschaft Magnetic particles for diagnostic purposes
DE3443251C2 (de) * 1984-11-23 1998-03-12 Schering Ag Eisenoxid-Komplexe für die NMR-Diagnostik, diese Verbindungen enthaltende diagnostische Mittel, ihre Verwendung und Verfahren zu deren Herstellung
US4640837A (en) 1985-10-15 1987-02-03 General Foods Corporation Coating composition for microwave cooking
US5160726A (en) * 1990-02-15 1992-11-03 Advanced Magnetics Inc. Filter sterilization for production of colloidal, superparamagnetic MR contrast agents
US5102652A (en) 1986-07-03 1992-04-07 Advanced Magnetics Inc. Low molecular weight carbohydrates as additives to stabilize metal oxide compositions
JP2858752B2 (ja) 1987-04-10 1999-02-17 オーソ・フアーマシユーチカル・コーポレーシヨン 正常な哺乳動物のヘマトクリツト値の増大方法
GB8902894D0 (en) 1989-02-09 1989-03-30 Fisons Plc Compositions
JP2726520B2 (ja) 1989-10-20 1998-03-11 名糖産業株式会社 有機磁性複合体
ATE124960T1 (de) 1989-11-10 1995-07-15 Tno Verfahren zur herstellung von polydicarboxysacchariden.
DE69223748T2 (de) 1991-06-11 1998-04-23 Meito Sangyo K.K., Nagoya, Aichi Oxidierte zusammensetzung, enthaltend ein wasserlösliches carboxypolysaccharid und magnetisches eisenoxid
TW293036B (es) 1992-11-27 1996-12-11 Takeda Pharm Industry Co Ltd
EP0634174A1 (en) 1993-07-13 1995-01-18 Takeda Chemical Industries, Ltd. Antianemic composition for veterinary use
NL194919C (nl) 1993-09-07 2003-07-04 Tno Werkwijze voor het oxideren van koolhydraten.
FR2720398B1 (fr) * 1994-05-26 1996-07-05 Commissariat Energie Atomique Complexes de métaux trivalents avec un polyol tel que le cis-inositol, utilisables à des fins médicales et leur procédé de préparation.
GB9514090D0 (en) 1995-07-11 1995-09-13 Cerestar Holding Bv Non-catalysed oxidation of maltodextrin with an oxygen containing oxidant
US5624668A (en) 1995-09-29 1997-04-29 Luitpold Pharmaceuticals, Inc. Iron dextran formulations
WO1997017377A1 (en) 1995-11-09 1997-05-15 Abbott Laboratories Process for making crystalline iron dextran
FR2742755B1 (fr) * 1995-12-21 1998-02-20 Roquette Freres Procede perfectionne d'oxydation des sucres
US5756715A (en) 1996-11-08 1998-05-26 Abbott Laboratories Process for making crystalline iron dextran
CA2195283C (en) 1997-01-16 2008-07-22 Thomas C. Usher Process for manufacturing iron dextran using ultrafiltration
IT1291289B1 (it) 1997-04-30 1999-01-07 Derivati Organici Lab Complessi costituiti da fe(iii) un composto poliidrossilato e ovalbumina
DK172860B1 (da) 1998-03-25 1999-08-16 Pharmacosmos Holding As Jerndextranforbindelse til anvendelse som komponent i et terapeutisk middel til forebyggelse af eller behandling af jernman
DE19833548A1 (de) 1998-07-25 2000-02-03 Messer Griesheim Gmbh Überkritische Fluorierung
US6587550B2 (en) 1998-09-02 2003-07-01 Michael O. Council Method and apparatus for enabling a fee to be charged to a party initiating an electronic mail communication when the party is not on an authorization list associated with the party to whom the communication is directed
DK173138B1 (da) 1998-11-20 2000-02-07 Pharmacosmos Holding As Fremgangsmåde til fremstilling af en jerndextranforbindelse, jerndextranforbindelse fremstillet efter fremgangsmåden, farma
US7871597B2 (en) 1999-04-09 2011-01-18 Amag Pharmaceuticals, Inc. Polyol and polyether iron oxide complexes as pharmacological and/or MRI contrast agents
JP5064612B2 (ja) 1999-04-09 2012-10-31 エーエムエージー ファーマシューティカルズ，インコーポレイテッド 還元された炭水化物類及び炭水化物誘導体で被覆された熱的に安定なコロイド状酸化鉄
US6703499B1 (en) 1999-04-29 2004-03-09 Polydex Pharmaceuticals Ltd. Process of making carboxylated dextran
US6521247B1 (en) 1999-08-13 2003-02-18 Warner Chilcott Laboratories Ireland Limited Dual iron containing nutritional supplement
US6495177B1 (en) 1999-08-13 2002-12-17 Warner Chilcott Laboratories Ireland Limited Orally dissolvable nutritional supplement
AT500063A1 (de) 1999-11-23 2005-10-15 Sandoz Ag Beschichtete tablettenkerne
US20020119174A1 (en) 2000-07-26 2002-08-29 Gardlik John Michael Compositions useful for regulating hair growth containing metal complexes of oxidized carbohydrates
US6929954B2 (en) * 2000-11-02 2005-08-16 Chromaceutical Advanced Technologies, Inc. Method for producing purified hematinic iron-saccharidic complex and product produced
CA2426799A1 (en) * 2000-11-02 2002-07-25 Chromaceutical Advanced Technologies, Inc. Method for producing purified hematinic iron-saccharidic complex and product produced
CN1353194A (zh) * 2000-11-02 2002-06-12 杨敏 生产20%右旋糖酐铁的方法
EP1719495A3 (en) 2000-11-02 2007-05-02 Chromaceutical Advanced Technologies, Inc. Method for producing purified hematinic iron-saccharidic complex and product produced
RU2003121403A (ru) * 2000-12-07 2004-12-27 АД "ЗДРАВЛЬЕ" Фармасеутско-кемийска индустри , Сентар за истразиванье и развой (YU) Полиядерный комплекс fe(iii) с олигомерами пуллулана, способ его получения и фармацевтические препараты на его основе
JP2002260951A (ja) 2000-12-28 2002-09-13 Denso Corp 積層型誘電素子及びその製造方法，並びに電極用ペースト材料
US20030191090A1 (en) 2002-04-09 2003-10-09 Pharmacosmos Holding A/S Iron dextrin compounds for the treatment of iron deficiency anaemia
MXPA04012863A (es) 2002-06-21 2005-03-31 Univ Pittsburgh Uso farmaceutico de oxido nitrico, heme oxigenasa-1 y productos de degradacion de heme.
US7169359B2 (en) * 2002-08-26 2007-01-30 Luitpold Pharmaceuticals, Inc. Bioequivalence test for iron-containing formulations
JP4408807B2 (ja) 2002-08-26 2010-02-03 ヴァイフォー（インターナショナル）アーゲー 鉄含有処方の生物学的等価性試験
DE10249552A1 (de) 2002-10-23 2004-05-13 Vifor (International) Ag Wasserlösliche Eisen-Kohlenhydrat-Komplexe, deren Herstellung und diese enthaltende Arzneimittel
US6960571B2 (en) * 2003-03-14 2005-11-01 Luitpold Pharmaceuticals, Inc. Methods and compositions for administration of iron for the treatment of restless leg syndrome
US20060116349A1 (en) 2003-03-14 2006-06-01 Luitpold Pharmaceuticals, Inc. Methods and compositions for administration of iron for the treatment of restless leg syndrome
US7964568B2 (en) * 2003-05-30 2011-06-21 Chromaceutical Advanced Technologies, Inc. Synthesis of high molecular weight iron-saccharidic complexes
US8614204B2 (en) 2003-06-06 2013-12-24 Fibrogen, Inc. Enhanced erythropoiesis and iron metabolism
JP2007509971A (ja) 2003-10-31 2007-04-19 アルザ・コーポレーシヨン メトホルミンの増加された吸収のための組成物及び投与形態物
US20060134227A1 (en) 2004-12-22 2006-06-22 Bortz Jonathan D Compositions including iron
ES2333814T3 (es) * 2005-02-09 2010-03-01 Vifor (International) Ag Uso de compuestos de complejo de hierro (iii).
US7815621B2 (en) * 2005-07-07 2010-10-19 Eisai R & D Management Co. Ltd. Recovery system
EP1757299A1 (de) 2005-08-25 2007-02-28 Vifor (International) Ag Eisen(III)-Komplexverbindungen zur Behandlung von Eisenmangel-Zuständen bei Patienten mit chronisch-entzündlicher Darmerkrankung
US7660481B2 (en) 2005-11-17 2010-02-09 Vital Images, Inc. Image enhancement using anisotropic noise filtering
EP1790356A1 (de) * 2005-11-24 2007-05-30 Vifor (International) Ag Präparat, umfassend Eisen(III)-Komplexverbindungen und redoxaktive Substanz(en)
WO2007081744A2 (en) 2006-01-06 2007-07-19 Luitpold Pharmaceuticals, Inc. Methods and compositions for administration of iron
US8778878B2 (en) 2007-01-29 2014-07-15 Chyna, LLC Use of ferritin to treat iron disorders
US8071542B2 (en) 2007-01-29 2011-12-06 Chyna, LLC Use of ferritin to treat iron deficiency disorders
EP1997833A1 (de) * 2007-05-29 2008-12-03 Vifor (International) Ag Wasserlösliche Eisen-Kohlenhydratderivat-Komplexe, deren Herstellung und diese enthaltende Arzneimittel
WO2011055374A2 (en) 2009-11-04 2011-05-12 Symed Labs Limited Process for the preparation of iron (iii) carboxymaltose complex
BRPI0904979A2 (pt) 2009-12-04 2011-07-19 Braskem Sa processo para produção de olefinas, olefina, poliolefina, e, uso da poliolefina
US9120838B2 (en) 2011-04-18 2015-09-01 Curators Of The University Of Missouri Saccharide conjugates
US8772101B2 (en) 2012-11-08 2014-07-08 Globalfoundries Inc. Methods of forming replacement gate structures on semiconductor devices and the resulting device
US20180105609A1 (en) 2015-03-23 2018-04-19 Suven Life Sciences Limited Preparation of water soluble trivalent iron carbohydrate complexes
WO2016181195A1 (en) 2015-05-08 2016-11-17 Suven Life Sciences Limited Improved process for water soluble iron carbohydrate complexes
EP3339329A1 (en) 2016-12-22 2018-06-27 LEK Pharmaceuticals d.d. Selective oxidation of maltodextrin and its use in the preparation of water-soluble iron (iii) carboxymaltose complexes

Also Published As

Publication number Publication date
EP1554315B1 (de) 2011-04-27
KR100992178B1 (ko) 2010-11-05
CN1705682A (zh) 2005-12-07
RU2005115455A (ru) 2005-12-10
BRPI0315452B1 (pt) 2015-12-01
EP1554315A1 (de) 2005-07-20
JOP20180046B1 (ar) 2022-09-15
US9376505B2 (en) 2016-06-28
CY1113387T1 (el) 2016-06-22
EP2287204B1 (de) 2012-05-30
DK1554315T3 (da) 2011-07-04
US20130203698A1 (en) 2013-08-08
ES2385788T3 (es) 2012-07-31
BR0315452A (pt) 2005-08-23
JP5289413B2 (ja) 2013-09-11
PE20040571A1 (es) 2004-10-01
US20060205691A1 (en) 2006-09-14
US10519252B2 (en) 2019-12-31
US7612109B2 (en) 2009-11-03
NO20052410L (no) 2005-07-18
US20190276563A1 (en) 2019-09-12
RU2303039C2 (ru) 2007-07-20
NO333008B1 (no) 2013-02-18
NO335770B1 (no) 2015-02-09
JP4777653B2 (ja) 2011-09-21
KR20050070014A (ko) 2005-07-05
ES2364136T3 (es) 2011-08-25
AU2003278111B2 (en) 2009-05-28
US11291645B2 (en) 2022-04-05
BRPI0315452B8 (pt) 2021-05-25
US20120316133A1 (en) 2012-12-13
IL166747A (en) 2010-11-30
BRPI0318840B1 (pt) 2021-02-02
US11123321B2 (en) 2021-09-21
US20210054105A1 (en) 2021-02-25
MXPA05004300A (es) 2005-11-23
SI1554315T1 (sl) 2011-09-30
JP2006505638A (ja) 2006-02-16
US20160215071A1 (en) 2016-07-28
US20190263939A1 (en) 2019-08-29
ATE507246T1 (de) 2011-05-15
ZA200504174B (en) 2006-04-26
IL166747A0 (en) 2006-01-15
WO2004037865A1 (de) 2004-05-06
BRPI0318840B8 (pt) 2021-05-25
JOP20180046A1 (ar) 2019-01-30
CA2493806C (en) 2014-02-11
DE10249552A1 (de) 2004-05-13
TW200420289A (en) 2004-10-16
TWI265028B (en) 2006-11-01
AU2003278111A1 (en) 2004-05-13
UY28033A1 (es) 2004-06-30
HK1149574A1 (en) 2011-10-07
US20100099647A1 (en) 2010-04-22
CA2493806A1 (en) 2004-05-06
NO20052410D0 (no) 2005-05-13
AU2003278111B8 (en) 2009-06-04
CN100480275C (zh) 2009-04-22
US20140371169A1 (en) 2014-12-18
MY134394A (en) 2007-12-31
DK2287204T3 (da) 2012-07-23
SA03240447B1 (ar) 2008-09-14
JOP20110173B1 (ar) 2021-08-17
US20220387371A1 (en) 2022-12-08
US11590097B2 (en) 2023-02-28
NZ539243A (en) 2007-05-31
JO3286B1 (ar) 2018-09-16
SI2287204T1 (sl) 2012-09-28
NO20110654L (no) 2005-07-18
PT1554315E (pt) 2011-06-30
PT2287204E (pt) 2012-07-18
US20210115163A1 (en) 2021-04-22
AU2003278111C1 (en) 2010-12-02
EP2287204A1 (de) 2011-02-23
DE50313653D1 (de) 2011-06-09
HK1081976A1 (en) 2006-05-26
JP2011052226A (ja) 2011-03-17
CY1112680T1 (el) 2016-02-10

Similar Documents

Publication Publication Date Title
AR041472A1 (es) Complejos de carbohidrato de hierro acuosos su produccion y medicamentos que los contienen
AR065997A1 (es) Complejos de hierro y derivados de carbohidratos, solubles en agua, su produccion y medicamentos que contienen los mismos
AR056055A1 (es) Complejos cristalinos e hidratos de 1-cloro-4-(beta-d-glucopiranos-1-il)-2-(4-etinil-bencil)-benceno
AR033510A1 (es) Inhibidores de la oxidacion parcial de acidos grasos para el tratamiento de la insuficiencia cardiaca congestiva
BR0312549A (pt) Derivados de indolin-fenilsulfonamida
RU2008111148A (ru) Применение комплексных соединений железа (iii) для производства лекарственного средства для перорального лечения железодефицитных состояний у больных, страдающих хроническими воспалительными заболеваниями кишечника
AR022076A1 (es) Composicion antioxidante constituida por acetil l-carnitina y acido alfa-lipoico para mejorar el aprovechamiento metabolico de la glucosa
CY1105127T1 (el) Συνθεση για την προληψη καρδιαγγειακων νοσων
AR018176A1 (es) Un complejo metaestable de calcio, proceso para prepararlo, los productos alimenticios fortificados con el mismo y los procedimientos para prepararlos.
AR035652A1 (es) Una composicion nutricional, util para combatir la infeccion en el tracto gastrointestinal causada por organismos tipo helicobacter, el uso de dicha composicion para la preparacion de medicamentos, o productos alimenticios y el procedimiento para preparar dicha composicion
TNSN08279A1 (en) Bayer healthcare ag
SI1594885T1 (sl) Zdravilo za inhibiranje rasti tumorjev
AR000087A1 (es) Proceso.
CY1111960T1 (el) Νεα φαρμακευτικα παρασκευασματα καθως επισης μεθοδος για την παρασκευη αυτων
ES2054941T3 (es) 4-sulfonilamino-2-acinil-1,2,4-triazol-3-onas substituidas, procedimientos asi como productos intermedios para su fabricacion y su utilizacion como herbicidas.
UY30705A1 (es) Sulfonamidas sustituidas
ES2049700T3 (es) Sal de la s-carboximetilcisteina lisina monohidratada y procedimiento para su fabricacion.
EA200701920A1 (ru) Использование фенилацетильных производных для производства лекарственных средств для лечения болезни фон хиппеля-линдау (vhl)
RU2003110485A (ru) Способ дезинфекции объектов окружающей среды
AR039883A1 (es) Combinacion farmaceutica
TH114614B (th) สารเชิงซ้อนอนุพันธ์เหล็ก-คาร์โบไฮเดรตที่ละลายน้ำได้ การเตรียมของมัน และเวชภัณฑ์ที่ประกอบด้วยสารเชิงซ้อนเหล่านี้
TH80175A (th) ไดแอซีเรนสำหรับใช้ในการบำบัดโรคเรื้อนกวาง
TH114614A (th) สารเชิงซ้อนอนุพันธ์เหล็ก-คาร์โบไฮเดรตที่ละลายน้ำได้ การเตรียมของมันและเวชภัณฑ์ที่ประกอบด้วยสารเชิงซ้อนเหล่านี้
ES2126865T3 (es) Derivados 1,5 disubstituidos del 7a-metilperhidroinden-3a-ol, activos sobre el sistema cardiovascular, procedimiento para su preparacion y composiciones farmaceuticas que los contienen.
ECSP003656A (es) Nuevos derivados del acido aminodicarboxilico con propiedades farmaceuticas

Legal Events

Date Code Title Description
FG Grant, registration